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predictive of AF development (Table).
Conclusions:
BMI was an independent predictor of first AF in this study of older adults. The potential
contribution of obesity to AF development warrants special attention, given the alarming
prevalence of both these public health problems.
11:45 a.m.
885-6 Prognostic Implications of Admission Hyperglycemia in 
Elderly Patients With Acute Myocardial Infarction
Mikhail Kosiborod, Saif S. Rathore, Yongfei Wang, Silvio E. Inzucchi, Frederick A. 
Masoudi, Edward P. Havranek, JoAnne M. Foody, Harlan M. Krumholz, Yale University 
School of Medicine, New Haven, CT, Denver Health Medical Center, Denver, CO
Background: Prior reports suggested that hyperglycemia is associated with poor out-
comes in patients (pts) with acute myocardial infarction (AMI), but were limited by size
and geographic constraints. We sought to examine the prognostic implications of hyperg-
lycemia in a large representative sample of elderly pts with AMI.
Methods: We evaluated a national sample of Medicare pts directly admitted for con-
firmed AMI between 1994-96, restricting analysis to pts >65 years with admission plasma
glucose of 50-600 mg/dL, known survival status and no terminal illness (n=142,060). Pts
were divided into quartiles (Q) based on admission glucose (Q1 50 - 119, Q2 120 - 149,
Q3 150 - 209, Q4 210-600 mg/dL). Multivariable logistic regression was used to test the
association between glucose and mortality at 30 days and 1 year.
Results: Higher glucose was associated with increased mortality at 30 days (Q1 11.4%,
Q2 14.8%, Q3 20.4%, Q4 27.1%, P<0.001) and 1 year (Q1 23.4%, Q2 27%, Q3 34.4%,
Q4 43.8%, P<0.001). This trend persisted in pts without known history of diabetes (DM)
for 30 day (Q1 11%, Q2 14.8%, Q3 22.1%, Q4 36.8%, P<0.001) and 1 year mortality (Q1
22.3%, Q2 26.4%, Q3 35.1%, Q4 52.4%, P<0.001). Adjusted mortality remained higher
in all pts with hyperglycemia, including those without prior history of DM (Table).
Conclusion: Admission hyperglycemia is associated with higher mortality in elderly pts
with AMI, including those without antecedent diagnosis of DM. Whether hyperglycemia is
a marker or mediator of higher risk is unknown.
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887-1 Combined Effects of Diastolic Dysfunction and Left 
Ventricular (LV) Remodeling on Mortality in 7,267 
Patients With Preserved LV Systolic Function
Richard V. Milani, Mandeep R. Mehra, Carl J. Lavie, Hector O. Ventura, Ochsner Clinic 
Foundation, New Orleans, LA
Background: We and others have published the adverse effects of diastolic dysfunction
(DD) and LV geometric patterns on mortality. To our knowledge the combined effects of
DD and LV remodeling has not been examined.
Methods: We assessed the impact of DD on mortality in patients with various LV struc-
tural profiles from a large echocardiographic database (n=7,267) and with normal systolic
function (EF >= 50%) (mean follow-up 3.1 years). Based on previously published criteria
utilizing relative wall thickness (RWT) (2 x posterior wall thickness / LV end diastolic
diameter; increased > 0.43), and LV mass index (LVMI) (increased > 104 g/m2 in women
and > 116 g/m2 in men), we classified patients as normal (normal RWT and LVMI), CR
(increased RWT, normal LVMI), CH (increased RWT and increased LVMI) and EH (nor-
mal RWT, increased LVMI). DD was identified based on established Doppler derived
mitral inflow patterns.
Results: The prevalence of normal cardiac structure was 54% (n=3,924), CR 35%
(n=2,543), EH 5% (n=363) and CH 6% (n=436). See figure for mortality results.
Conclusions: Cardiac remodeling in patients with preserved LV systolic function is asso-
ciated with an increase in mortality. DD nearly doubles mortality in all LV structural pro-
files and is particularly pathogenic when identified with adverse remodeling.
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887-2 Cardiogenic Shock in Patients With Preserved Left 
Ventricular Systolic Function: Characteristics and 
Insight Into Mechanisms
Krishnan Ramanathan, Shannon M. Harkness, Ambika C. Nayar, John E. Cosmi, Lynn S. 
Sleeper, Harvey D. White, Ravin Davidoff, Judith S. Hochman, New York University 
School of Medicine, New York, NY
Background: Traditionally, very poor left ventricular (LV) function with low ejection frac-
tion (EF) is considered the hallmark necessary for developing cardiogenic shock (CS)
due to predominant LV failure in acute myocardial infarction (MI). In the SHOCK trial,
patients with preserved (LVEF) developed CS, challenging this paradigm. We report the
clinical and 2-D echocardiographic (Echo) characteristics of patients with preserved
LVEF in the SHOCK trial and suggest a mechanism for CS post-MI.
Methods: We retrospectively studied SHOCK trial (n=97) patients who had core lab
assessment of Echo performed at the time of randomization and before revasculariza-
tion, excluding patients with a mechanical cause of CS. The patients were subdivided
into quartiles (Q1 to 4) based upon initial LVEF for comparison between Q1 (EF >37%;
n=24) and Q2-4 (EF </=37%).
Results: The Q1 group had lower incidence of prior MI or history of hypertension (38
vs.73%), lower mean pulmonary wedge pressure (21 ±8 vs. 24±7mmHg; p<0.05 for both)
and a trend towards lower heart rate (94±25 vs.103±21 per min; p=0.09).
Otherwise the groups had similar baseline characteristics, thrombolytic use, peak CPK,
initial hemodynamics, cardiac index, SVR and time from CS diagnosis to LVEF measure
(median 4.8 vs.7.1h; p=0.78). The groups were similar for right ventricular size and func-
tion, remote zone wall motion score index and mitral or aortic regurgitation. In 35 patients
with measure of transmitral filling patterns, the prevalence of a restrictive filling pattern
defined as E:A ratio>2 or E:A ratio 1-2 with MDT <141msec was similar in both groups
(p=0.06). The Q1 group had significantly lower LV end-diastolic (96± 45 vs. 119± 38 ml)
and end-systolic volume and a higher proportion with normal LV size range (79 vs. 42%)
and EF (47±7 vs. 25±7%) p<0.01 for all. Although stroke volume index (SVI) was higher
in Q1 (34 ± 22 vs 21± 10ml/m2; p<0.01), it was low for all groups.
Conclusions: Patients developing CS with an EF >37% have non-dilated, small sized-
LVs. We propose that acute LV dilation is an adaptive compensation for large MIs to
maintain SV and lack of acute dilation predisposes to CS, perhaps most importantly in
association with abnormal vascular tone.
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887-3 What Proportion of Patients With Heart Failure and 
Preserved Left Ventricular Systolic Function Has an 
Elevated Plasma Concentration of B-Type Natriuretic 
Peptide?
Karen J. Hogg, Esther Rooney, Eileen Lundmark, James Christie, Edward Newman, 
David Kay, John J.V McMurray, Glasgow University, Glasgow, United Kingdom
BACKGROUND: Many patients admitted to hospital with a clinical diagnosis of “heart
failure” are found to have preserved left ventricular (LV) systolic function. There remains,
however, a great deal of uncertainty as to whether or not these patients really do have
heart failure. We have determined the proportion of such patients in which there is bio-
chemical evidence of LV compromise i.e. those who have an increased plasma concen-
tration of B type natriuretic peptide (BNP).
METHODS: 2725 near consecutive emergency admissions were screened for clinical
signs of heart failure. 167 fulfilled the criteria and had heart failure according to at least
one of the three standard heart failure classification systems (Boston, NHANES and
Framingham). Their mean age was 75 years and 56% were female. Trans-thoracic
echocardiography (TTE) was performed and plasma BNP concentrations measured. An
Multivariate clinical model for prediction of AF
Variable HR 95%CI P-value
Age, year 1.044 1.025-1.065 <0.0001
Male gender 1.344 1.014-1.781 0.0397
Valvular heart disease 1.750 1.264-2.423 0.0007
History of congestive heart failure 2.778 1.986-3.885 <0.0001
History of myocardial infarction 1.805 1.330-2.452 0.0002
Diabetes mellitus 1.208 0.800-1.822 0.3687
Hypertension 1.418 1.071-1.878 0.0147
BMI, per 10 kg/m2 1.335 1.027-1.736 0.0309
Risk ratios with 95% confidence intervals
Q1 Q2 Q3 Q4
All patients
30-day mortality 1.00-referent 1.21 (1.17, 1.27) 1.51 (1.44, 1.57) 1.93 (1.84, 2.01)
1-year mortality 1.00-referent 1.13 (1.09, 1.16) 1.31 (1.27, 1.35) 1.57 (1.52, 1.62)
Patients without diabetes
30-day mortality 1.00-referent 1.25 (1.20, 1.31) 1.59 (1.52, 1.67) 2.03 (1.92, 2.13)
1-year mortality 1.00-referent 1.15 (1.11, 1.18) 1.36 (1.32, 1.41) 1.66 (1.59, 1.73)
